Terms: = Endocrine gland cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715 AND Prognosis
11 results:
1. Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study.
Zou S; Wang X; Chen H; Lin J; Wen C; Zhan Q; Chen H; Lu X; Deng X; Shen B
BMC Cancer; 2022 Jun; 22(1):649. PubMed ID: 35698045
[TBL] [Abstract] [Full Text] [Related]
2. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
[No Abstract] [Full Text] [Related]
3. CCAAT enhancer binding protein α suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling.
Zhang LM; Li M; Tian CC; Wang TT; Mi SF
Neoplasma; 2021 May; 68(3):602-612. PubMed ID: 33780265
[TBL] [Abstract] [Full Text] [Related]
4. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic cancer: State of the Field and the Impact of the EDRN.
Liu Y; Kaur S; Huang Y; Fahrmann JF; Rinaudo JA; Hanash SM; Batra SK; Singhi AD; Brand RE; Maitra A; Haab BB
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2513-2523. PubMed ID: 32532830
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
[TBL] [Abstract] [Full Text] [Related]
6. The significance of c.690G>T polymorphism (rs34529039) and expression of the cebpa gene in ovarian cancer outcome.
Konopka B; Szafron LM; Kwiatkowska E; Podgorska A; Zolocinska A; Pienkowska-Grela B; Dansonka-Mieszkowska A; Balcerak A; Lukasik M; Stachurska A; Timorek A; Spiewankiewicz B; El-Bahrawy M; Kupryjanczyk J
Oncotarget; 2016 Oct; 7(41):67412-67424. PubMed ID: 27602952
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of prognostic factors and a proposed new classification for invasive papillary mucinous neoplasms.
Jang JY; Hwang DW; Kim MA; Kang MJ; Lim CS; Lee SE; Kim SW
Ann Surg Oncol; 2011 Mar; 18(3):644-50. PubMed ID: 20924796
[TBL] [Abstract] [Full Text] [Related]
8. Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations.
Cao D; Antonescu C; Wong G; Winter J; Maitra A; Adsay NV; Klimstra DS; Hruban RH
Mod Pathol; 2006 Sep; 19(9):1157-63. PubMed ID: 16778826
[TBL] [Abstract] [Full Text] [Related]
9. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.
Merati K; said Siadaty M; Andea A; Sarkar F; Ben-Josef E; Mohammad R; Philip P; Shields AF; Vaitkevicius V; Grignon DJ; Adsay NV
Am J Clin Oncol; 2001 Oct; 24(5):447-52. PubMed ID: 11586094
[TBL] [Abstract] [Full Text] [Related]
10. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation.
Lüttges J; Schemm S; Vogel I; Hedderich J; Kremer B; Klöppel G
J Pathol; 2000 Jun; 191(2):154-61. PubMed ID: 10861575
[TBL] [Abstract] [Full Text] [Related]
11. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.
Iwama T; Mishima Y; Utsunomiya J
Ann Surg; 1993 Feb; 217(2):101-8. PubMed ID: 8382467
[TBL] [Abstract] [Full Text] [Related]